Abstract
Lung cancers are very heterogeneous, a feature that in part emanates from the tumor microenvironment. In this issue, Salcher et al. provide a comprehensive analysis of hundreds of patients with non-small cell lung cancer (NSCLC) at the single-cell level to discover extreme immune diversity and define neutrophil populations associated with treatment outcome.
Original language | English |
---|---|
Pages (from-to) | 1459-1461 |
Number of pages | 3 |
Journal | Cancer Cell |
Volume | 40 |
Issue number | 12 |
DOIs |
|
State | Published - 12 Dec 2022 |
Externally published | Yes |